Laddar...
Recent advances in T-cell engineering for use in immunotherapy
Adoptive T-cell therapies have shown exceptional promise in the treatment of cancer, especially B-cell malignancies. Two distinct strategies have been used to redirect the activity of ex vivo engineered T cells. In one case, the well-known ability of the T-cell receptor (TCR) to recognize a specific...
Sparad:
| I publikationen: | F1000Res |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
F1000Research
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5031132/ https://ncbi.nlm.nih.gov/pubmed/27703664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.9073.1 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|